Peptide Schedule
Endoluten5 residuesAEDLVEach bubble = one amino acid. Size = residue mass. Color = chemical class.Endoluten
Benefits
About Endoluten
Endoluten is a pineal gland peptide bioregulator developed as part of Vladimir Khavinson's decades-long research program into organ-specific peptide therapy. It's produced by acid extraction and chromatographic purification of pineal tissue from calves under 12 months old. Mass spectrometry has confirmed the presence of AEDG tetrapeptide (the synthetic version of which is Epithalon) among its bioactive components. The preparation also contains the tripeptide EDR (Glu-Asp-Arg), independently studied for neuroprotective properties. Russian gerontological research spanning over 20 years has shown that pineal peptide preparations can restore nighttime melatonin secretion in elderly subjects and normalize the hormone's circadian rhythm. A landmark 6-8 year follow-up study of 266 elderly participants found that combined pineal and thymic peptide treatment reduced mortality rates up to 4.1-fold compared to controls. While Endoluten's clinical evidence is concentrated in Russian-language literature, the underlying peptide components (AEDG and EDR) have been characterized in international peer-reviewed journals.
Who Should Consider Endoluten
- Elderly adults with declining melatonin production and disrupted sleep patterns
- Individuals seeking non-invasive peptide bioregulation for anti-aging support
- Adults with circadian rhythm disruption
- Researchers studying Khavinson peptide bioregulators and pineal gland function
How Endoluten Works
Endoluten's activity stems from its constituent short-chain peptides interacting with pinealocyte gene promoter regions to restore melatonin biosynthesis. The AEDG tetrapeptide component activates telomerase and normalizes melatonin synthesis in the pineal gland, while the EDR tripeptide component regulates the MAPK/ERK signaling pathway, inhibiting ERK1/2 activation under conditions of oxidative stress. EDR also upregulates superoxide dismutase 2 (SOD2) and glutathione peroxidase 1 (GPx1) expression in brain tissue. At the cellular level, Endoluten's peptides reduce caspase-3-mediated apoptosis in neural tissue and preserve dendritic spine morphology.
What to Expect
Minimal noticeable effects. Some users report subtle improvements in sleep onset.
Gradual improvement in sleep quality and duration as melatonin synthesis begins to normalize.
Peak effects of the initial course. More consistent sleep-wake patterns and improved subjective energy levels in responsive individuals.
Benefits typically persist for several months after completing a 10-day course due to lasting epigenetic changes in pinealocyte gene expression.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 10mg | Daily |
| Moderate | 20mg | Daily |
| Aggressive | 20mg | 2x Daily |
Note: Endoluten (A-8) is a polypeptide bioregulator complex extracted from the pineal gland of young calves, containing short-chain peptides including EDR (Glu-Asp-Arg, also known as Pinealon) and AEDG (the active sequence in Epithalon). Taken orally as capsules, typically 1-2 capsules daily for 10-day courses repeated every 3-6 months. Each capsule contains approximately 10 mg of the purified peptide complex.
How to Inject Endoluten
Take 1-2 capsules orally, 10-15 minutes before a meal, with water. Standard preventive protocol is 2 capsules daily for 10 consecutive days. Courses are repeated every 3-6 months. Morning dosing is preferred for the first capsule.
Cycling Protocol
Standard Khavinson bioregulator protocol: 1-2 capsules daily for 10 days, repeated every 3-6 months. For more pronounced conditions, courses of 15-60 days have been used under medical supervision.
Pharmacokinetics
Source: Estimated from polypeptide fraction kinetics; individual component PK not characterized (Khavinson & Morozov, 2003)
Loading the interactive decay curve.
Side Effects
Endoluten is generally well tolerated. The most commonly noted side effects include mild GI discomfort, headache, and transient drowsiness likely related to increased melatonin production. Because it's derived from bovine pineal tissue, individuals sensitive to animal-derived proteins should exercise caution. Theoretical prion-related concerns exist with any bovine brain-derived product, though no cases have been documented.
Contraindications
- Pregnancy and breastfeeding (insufficient safety data)
- Children and adolescents under 18 years of age
- Known hypersensitivity to bovine-derived proteins or peptides
- Active autoimmune conditions (may modulate immune function)
Drug Interactions
- May potentiate the effects of exogenous melatonin supplements
- Caution with sedatives and sleep medications due to additive drowsiness from increased endogenous melatonin
- Theoretical interaction with immunosuppressants due to immune-modulating properties of pineal peptides
- No formal drug interaction studies have been conducted
Storage & Stability
Molecular Profile
Related Peptides
References
- Peptides of pineal gland and thymus prolong human lifePubMed 14523363
- EDR Peptide: Possible Mechanism of Gene Expression Regulation in Alzheimer's DiseasePubMed 33396470
- Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly peoplePubMed 17969590
- Identification of Peptide AEDG in the Polypeptide Complex of the Pineal GlandPubMed 29124531
- Melatonin and pineal gland peptides correct impairment of reproductive cycles in ratsPubMed 23237594